Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges

Authors

Ming Xia

Published

December 1, 2024

Abstract

Supporters

Support the authors with ResearchCoin

Journal

Vaccine

Topics

DOI

10.1016/j.vaccine.2024.126585

Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges

Authors

Ming Xia

Published

December 1, 2024

Abstract

Supporters

Support the authors with ResearchCoin

Journal

Vaccine

Topics

DOI

10.1016/j.vaccine.2024.126585

Paper

Paper

Paper

Paper

Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges

Abstract

Supporters

Journal

Topics

DOI

Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges

Abstract

Supporters

Journal

Topics

DOI